Syndesi’s goal is to demonstrate the potential of novel modulators of SV2A to reduce the symptoms of cognitive impairment in patients with Alzheimer’s Disease and related conditions.
Maison de l’Industrie Technologique
Rue Auguste Piccard, 20
6041 Gosselies (Belgium)
Tel : +32 71 91 92 85
Email : [email protected]
© 2021 Biowin.